Filter the drugs by their status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Latest database update
Number of references
Ivermectin Potential treatment - clinical evidence Used to treat other disease Antiviral Oct/12/2020 Oct/17/2020 0
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Sep/23/2020 Oct/19/2020 0
Fidaxomicin Potential treatment - theoretical effect Used to treat other disease Antiviral Sep/17/2020 Oct/13/2020 0
[2-[[(3R)-1,1-Dioxothiolan-3-yl]-(2-methylpropyl)amino]-2-oxoethyl] 3-(furan-2-carbonylamino)-4-methylbenzoate Potential treatment - theoretical effect Experimental Antiviral Sep/17/2020 Oct/13/2020 0
Rifabutin Potential treatment - theoretical effect Used to treat other disease Antiviral Sep/17/2020 Oct/13/2020 0
Rifapentine Potential treatment - theoretical effect Used to treat other disease Antiviral Sep/17/2020 Oct/13/2020 0
[2-[[(2R)-Butan-2-yl]-[(3R)-1,1-dioxothiolan-3-yl]amino]-2-oxoethyl] 3-(furan-2-carbonylamino)-4-methylbenzoate Potential treatment - theoretical effect Experimental Antiviral Sep/17/2020 Oct/13/2020 0
Ad26.COV2.S Potential treatment - pre-clinical evidence Experimental Vaccine Sep/03/2020 Oct/13/2020 0